ProPhase Labs, Inc. Other Accrued Liabilities, Current
ProPhase Labs, Inc. (PRPH) had Other Accrued Liabilities, Current of $265.00 thousand as of 2017-03-31, per its 10-Q/A filed 2018-08-20.
Discontinued › Notes › Accrued Liabilities, Current
us-gaap:OtherAccruedLiabilitiesCurrent · last filed 2018-08-20
- 2017-03-31: Other Accrued Liabilities, Current $265.00K.
- 2016-12-31: Other Accrued Liabilities, Current $219.00K; Other Accrued Liabilities, Current as first filed $170.00K.
- 2015-12-31: Other Accrued Liabilities, Current $484.00K.
- 2014-12-31: Other Accrued Liabilities, Current $372.00K.
| Period end | Other Accrued Liabilities, Current | Other Accrued Liabilities, Current as first filed |
|---|---|---|
| 2017-03-31 | $265.00K 10-Q/A · filed 2018-08-20 | |
| 2016-12-31 | $219.00K 10-Q/A · filed 2018-08-20 | $170.00K 10-K · filed 2017-02-24 |
| 2015-12-31 | $484.00K 10-K · filed 2017-02-24 | |
| 2014-12-31 | $372.00K 10-K · filed 2016-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |